Ekso Bionics Holdings Inc <EKSO.OQ> expected to post a loss of $1.35 a share - Earnings Preview
Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected to show a fall in quarterly revenue when it reports results on July 28 for the period ending June 30 2025
The San Rafael California California-based company is expected to report a 12.9% decrease in revenue to $4.313 million from $4.95 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Ekso Bionics Holdings Inc is for a loss of $1.35 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $37.50, about 87.4% above its last closing price of $4.72
This summary was machine generated July 25 at 20:34 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
